Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer

被引:26
|
作者
Fukui, Kayo [1 ]
Masumoto, Norio [2 ]
Shiroma, Noriyuki [3 ]
Kanou, Akiko [1 ]
Sasada, Shinsuke [2 ]
Emi, Akiko [2 ]
Kadoya, Takayuki [2 ]
Yokozaki, Michiya [1 ]
Arihiro, Koji [3 ]
Okada, Morihito [2 ]
机构
[1] Hiroshima Univ Hosp, Div Lab Med, Hiroshima, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7340037, Japan
[3] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan
基金
日本学术振兴会;
关键词
Breast cancer; Tumor-infiltrating lymphocytes; Lymphocyte-predominant breast cancer; Ultrasonography; SCREENING MAMMOGRAPHY; MALIGNANCY GRADE; PROGNOSTIC VALUE; FREE SURVIVAL; US; CHEMOTHERAPY; TRASTUZUMAB; ASSOCIATION; TOMOGRAPHY; BENIGN;
D O I
10.1007/s12282-019-00958-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The presence of tumor-infiltrating lymphocytes (TILs) is a prognostic factor for breast cancer. However, because of tumor tissue heterogeneity, an accurate and simple evaluation method is needed. We determined if preoperative characteristic ultrasonography (US) image findings are predictive of lymphocyte-predominant breast cancer (LPBC). Methods We evaluated 191 patients with invasive breast cancer treated by curative surgery between January 2014 and December 2017. Stromal lymphocytes in surgical pathological specimens were evaluated. Fifty-two patients with >= 50% stromal TILs were defined as having LPBC. Preoperative US images were examined for indicators of TILs. The US images with characteristic TILs were scored for prediction of LPBC. Results Shape (more lobulated), internal echo level (weaker), and posterior echoes (stronger) were predictors of LPBC and used to assign the TILs-US scores (0-7 points); the score cutoff for predicting LPBC was 4 points (sensitivity, 0.73; specificity, 0.87; accuracy, 0.83) based on the receiver operating characteristics (ROC) curves (AUC 0.88). Multivariate logistic regression analysis identified nuclear grade (NG), OR 3.4; estrogen receptor (ER), OR 5.7; human epidermal growth factor receptor type-2 (HER2), OR 4.1; and TILs-US score, OR 14.9 as LPBC predictors (all, p < 0.05). The sensitivity, specificity, and accuracy for predicting LPBC were 0.75, 0.69, and 0.71 for NG and 0.33, 0.96, and 0.79 for ER and HER2, respectively. ROC analysis showed that the diagnostic abilities of NG, ER, and HER2 were lower than that of the TILs-US score. Conclusions LPBC showed characteristic US imaging findings. The TILs-US score was an accurate preoperative predictor of LPBC.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 50 条
  • [21] Diagnostic and Therapeutic Implications of Tumor-Infiltrating Lymphocytes in Breast Cancer
    Denkert, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 836 - 837
  • [22] Tumor-Infiltrating Lymphocytes in Breast Cancer: Ready for Prime Time?
    Ocana, Alberto
    Diez-Gonzalez, Laura
    Adrover, Encarna
    Fernandez-Aramburo, Antonio
    Pandiella, Atanasio
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1298 - +
  • [23] Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
    Loi, Sherene
    ONCOIMMUNOLOGY, 2013, 2 (07)
  • [24] Significance of tumor-infiltrating lymphocytes in breast cancer with neoadjuvant chemotherapy
    Miyoshi, Y.
    Shien, T.
    Omori, M.
    Abe, Y.
    Watanabe, A.
    Hara, A.
    Mizoo, T.
    Nogami, T.
    Taira, N.
    Doihara, H.
    BREAST, 2015, 24 : S124 - S124
  • [25] In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
    Camp, BJ
    Dyhrman, ST
    Memoli, VA
    Mott, LA
    Barth, RJ
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (02) : 176 - 184
  • [26] Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
    Feng, Jikun
    Li, Jianxia
    Huang, Xinjian
    Yi, Jiarong
    Wu, Haoming
    Zou, Xuxiazi
    Zhong, Wenjing
    Wang, Xi
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [27] Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression
    Fassler, Danielle J.
    Torre-Healy, Luke A.
    Gupta, Rajarsi
    Hamilton, Alina M.
    Kobayashi, Soma
    Van Alsten, Sarah C.
    Zhang, Yuwei
    Kurc, Tahsin
    Moffitt, Richard A.
    Troester, Melissa A.
    Hoadley, Katherine A.
    Saltz, Joel
    CANCERS, 2022, 14 (09)
  • [28] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Leon-Ferre, Roberto A.
    Jonas, Sarah Flora
    Salgado, Roberto
    Loi, Sherene
    de Jong, Vincent
    Carter, Jodi M.
    Nielsen, Torsten O.
    Leung, Samuel
    Riaz, Nazia
    Chia, Stephen
    Jules-Clement, Gerome
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Cockenpot, Vincent
    Lambertini, Matteo
    Suman, Vera J.
    Linderholm, Barbro
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Timmermans, A. Mieke
    Shimoi, Tatsunori
    Yazaki, Shu
    Yoshida, Masayuki
    Kim, Sung-Bae
    Lee, Hee Jin
    Dieci, Maria Vittoria
    Bataillon, Guillaume
    Vincent-Salomon, Anne
    Andre, Fabrice
    Kok, Marleen
    Linn, Sabine C.
    Goetz, Matthew P.
    Michiels, Stefan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
  • [29] Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer
    Ma, Xingcong
    Zhao, Xiaoyao
    Yan, Wanjun
    Yang, Jun
    Zhao, Xixi
    Zhang, Hong
    Hui, Yuxin
    Zhang, Shuqun
    CANCER BIOMARKERS, 2018, 21 (03) : 639 - 650
  • [30] Role of tumor-infiltrating gammadelta T lymphocytes in breast cancer
    Ma, Chunling
    Zhang, Qunyuan
    Ye, Jian
    Zhang, Yanping
    Wevers, Eric
    Schwartz, Theresa
    Hunborg, Pamela
    Vavares, Mark A.
    Hoft, Daniel F.
    Hsueh, Eddy C.
    Peng, Guangyong
    CANCER RESEARCH, 2012, 72